Devona Williams, PharmD, BCOP

All articles by Devona Williams, PharmD, BCOP

Administering bevacizumab before etoposide and cisplatin may be highly effective in patients with br

Ribociclib Shown to Penetrate the Blood-Brain Barrier in Glioblastoma

September 25, 2019

A phase 0 study of ribociclib in patients with recurrent glioblastoma seeks to inform the feasibility of the use of CDK 4/6 inhibitors for deadly brain tumors.

Next post in Brain Cancer

Devona Williams, PharmD, BCOP

All articles by Devona Williams, PharmD, BCOP

Ribociclib Shown to Penetrate the Blood-Brain Barrier in Glioblastoma

Interferon Alfa Improves Upon Standard Care in High Grade Glioma